Not Yet RecruitingNot Applicable

Application of Antiosteoporosis Therapy in Osteolysis

China100 participantsStarted 2024-12-28

Plain-language summary

To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. No age restriction, male or female.
✓. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.
✓. Received excision of bone tumor in research institution.

What they're measuring

Complications

Timeframe: Collected from the beginning of treatment to 24 months after treatment.

Limb function

Timeframe: Collected from the beginning of treatment to 24 months after treatment.

Trial details

NCT IDNCT05617846

SponsorHenan Cancer Hospital

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2032-11-30

View on ClinicalTrials.gov More Limb; Fusion trials